Updated:
Rubius Therapeutics, Inc.
Rubius Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001709401, and its reported...
Overview
Rubius Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001709401, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2023-02-27, it reported annual revenue of USD 0; net income of USD -179,666,000; total assets of USD 23,070,000 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Rubius Therapeutics, Inc.
- Classification
- Company
- Industry (SIC)
- 2836 — Biological Products, (No Diagnostic Substances)
- Headquarters
- Foxboro, MA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001709401
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2022USD | $0 | -$179.7M | $23.1M | $14.9M | -$150.1M | |
| FY2021USD | — | -$196.5M | $318.0M | $225.8M | -$145.1M | |
| FY2020USD | — | -$167.7M | $277.8M | $91.2M | -$127.6M | |
| FY2019USD | — | -$163.5M | $394.8M | $91.9M | -$110.4M |
FY2021. Net income: shown as originally filed; later filings report different values for the same periods.
FY2020. Net income: shown as originally filed; later filings report different values for the same periods.
FY2019. Net income: shown as originally filed; later filings report different values for the same periods.
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | FORM 8-K | ||
| DEF 14A | DEF 14A | ||
| 8-K | FORM 8-K | ||
| 10-K | 10-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Rubius Therapeutics, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.